MWNA
EVH icon

Marshall Wace North America’s Evolent Health EVH Stock Holding History

Marshall Wace North America’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$8.53M Buy
274,976
+225,615
+457% +$5.42M 0.04% 389
2021
Q2 		$1.04M Sell
49,361
-7,695
-13% -$154K ﹤0.01% 998
2021
Q1 		$1.15M Buy
+57,056
New +$1.09M ﹤0.01% 997
2019
Q4 		– Sell
-32,063
Closed -$230K – 1370
2019
Q3 		$230K Sell
32,063
-579,906
-95% -$4.16M ﹤0.01% 940
2019
Q2 		$4.87M Buy
611,969
+329,666
+117% +$3.9M 0.03% 372
2019
Q1 		$3.55M Buy
282,303
+269,899
+2,176% +$4.27M 0.03% 381
2018
Q4 		$247K Buy
+12,404
New +$287K ﹤0.01% 919
2018
Q3 		– Sell
-657,387
Closed -$13.8M – 1044
2018
Q2 		$13.8M Buy
+657,387
New +$12.4M 0.08% 266
2018
Q1 		– Sell
-72,660
Closed -$894K – 1505
2017
Q4 		$894K Sell
72,660
-101,842
-58% -$1.44M ﹤0.01% 1017
2017
Q3 		$3.14M Buy
174,502
+105,750
+154% +$2.18M 0.02% 675
2017
Q2 		$1.72M Sell
68,752
-665,010
-91% -$16M 0.01% 787
2017
Q1 		$16.1M Buy
+733,762
New +$14.1M 0.13% 200

Other funds holding EVH

EC
Engaged Capital Newport Beach, California $327M AUM 22.96% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.81B AUM 83.9% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return

Marshall Wace North America's EVH Position: Q3 2021 in Review

Marshall Wace North America increased its Evolent Health (EVH) stake by 457% in Q3 2021, buying an estimated $5.42M and bringing the position to 274,976 shares worth $8.53M. The position accounts for 0.04% of the portfolio, ranked #389.

Marshall Wace North America first reported a position in EVH in Q1 2017 and has held it in 12 quarters since. The position peaked at $16.1M in Q1 2017. 209 funds tracked by Wall St. Rank hold EVH as of Q3 2021.

  • Marshall Wace North America held 274,976 shares of Evolent Health worth $8.53M as of Q3 2021.
  • Marshall Wace North America bought 225,615 Evolent Health shares in Q3 2021, an estimated $5.42M.
  • Evolent Health made up 0.04% of Marshall Wace North America's portfolio in Q3 2021, its #389 holding.
  • Marshall Wace North America first reported a position in Evolent Health in Q1 2017 and has held it in 12 quarters since.
  • Marshall Wace North America's Evolent Health position peaked at $16.1M in Q1 2017.
  • 209 funds tracked by Wall St. Rank held Evolent Health as of Q3 2021.

Based on Marshall Wace North America's 13F filing for Q3 2021, filed 15 Nov 2021.